Colleen Cutcliffe is the founder of Pendulum Therapeutics. Pendulum Therapeutics has raised $111M in total funding. Latest round: Series C.
Colleen Cutcliffe, PhD, is the co-founder and CEO of Pendulum Therapeutics, a biotech startup headquartered in San Francisco that develops probiotics targeting gut health and microbiome-related conditions. She founded the company in 2012–2013 and has led it to secure over $111 million in venture funding.
Full founder directory · Investor directory · Company funding database · Fundraising library